Reports for CHEPLAPHARM ARZNEIMITTEL GMBH

Company Name

CHEPLAPHARM ARZNEIMITTEL GMBH

Totals

Shortage reports

48

Actual shortage: 7 (15%)
Anticipated shortage: 0 (0%)
Avoided shortage: 1 (2%)
Resolved: 40 (83%)

Discontinuation Reports

4

To be discontinued: 0 (0%)
Discontinued: 4 (100%)
Reversed: 0 (0%)

Late reports

4 (8%)

Overdue reports

4 (57%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
VALCYTE 450MG TABLET Resolved 2023-05-02 2023-05-25 191490
VALCYTE 450MG TABLET Resolved 2023-09-27 2023-11-05 205325
VALCYTE 450MG TABLET Resolved 2024-01-04 2024-02-01 214848
ONE-ALPHA 1MCG CAPSULE Resolved 2020-04-04 2020-05-16 110953
VALCYTE 50MG POWDER FOR SOLUTION Resolved 2023-05-02 2023-11-05 191497
FUNGIZONE 50MG POWDER FOR SOLUTION Resolved 2017-07-20 2019-05-23 16534
FUNGIZONE 50MG POWDER FOR SOLUTION Resolved 2022-11-10 2023-02-14 174215
LOSEC 20MG CAPSULE (DELAYED RELEASE) Resolved 2021-12-13 2022-05-25 151043

Showing 41 to 48 of 48

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
LOSEC 20MG TABLET (DELAYED-RELEASE) Discontinued 2021-11-19 2021-11-19 149669
SUPREFACT 100MCG SOLUTION Discontinued 2021-12-13 2021-12-13 151039
XELODA 150MG TABLET Discontinued 2022-11-30 2022-12-01 176355
XELODA 500MG TABLET Discontinued 2022-11-30 2022-12-01 176359

Showing 1 to 4 of 4